BBP · Virtus Biotech Etf ETF
ETFis Series Trust I
$108.33
-0.49%
At close · Sep 4
Net assets $59,287,650
Holdings55
1 month
+7.93%
Year to date
+35.55%
52-week range
$68.05–$110.05
30-session avg volume
9,543
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000047354
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| IMMUNITYBIO INC | IBRX | $2,847,136 | 4.80% |
| APELLIS PHARMACEUTICALS INC | 03753U106 | $1,535,994 | 2.59% |
| KALVISTA PHARMACEUTICALS INC | 483497103 | $1,492,000 | 2.52% |
| MODERNA INC | MRNA | $1,475,685 | 2.49% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | $1,445,361 | 2.44% |
| MIRUM PHARMACEUTICALS INC | MIRM | $1,416,639 | 2.39% |
| AXSOME THERAPEUTICS INC | AXSM | $1,326,692 | 2.24% |
| ZAI LAB LTD | ZLAB | $1,152,460 | 1.94% |
| LIGAND PHARMACEUTICALS | LGND | $1,145,414 | 1.93% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | $1,145,137 | 1.93% |
| TRAVERE THERAPEUTICS INC | TVTX | $1,144,400 | 1.93% |
| NOVAVAX INC | NVAX | $1,141,549 | 1.93% |
| UNITED THERAPEUTICS CORP | UTHR | $1,093,564 | 1.84% |
| GERON CORP | GERN | $1,071,626 | 1.81% |
| BIONTECH SE | BNTX | $1,032,534 | 1.74% |
| AMGEN INC | AMGN | $1,030,786 | 1.74% |
| EXELIXIS INC | EXEL | $1,029,160 | 1.74% |
| BIOGEN INC | BIIB | $1,028,548 | 1.73% |
| GILEAD SCIENCES INC | GILD | $1,028,272 | 1.73% |
| TG THERAPEUTICS INC | TGTX | $1,019,717 | 1.72% |
| KRYSTAL BIOTECH INC | KRYS | $1,013,897 | 1.71% |
| LEGEND BIOTECH CORP | LEGN | $997,201 | 1.68% |
| SYNDAX PHARMACEUTICALS INC | SNDX | $995,574 | 1.68% |
| ARROWHEAD PHARMACEUTICALS INC | ARWR | $992,053 | 1.67% |
| AGIOS PHARMACEUTICALS INC | AGIO | $971,684 | 1.64% |
| HALOZYME THERAPEUTICS INC | HALO | $968,332 | 1.63% |
| ARDELYX INC | ARDX | $964,648 | 1.63% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | $956,903 | 1.61% |
| INCYTE CORP | INCY | $944,888 | 1.59% |
| AURINIA PHARMACEUTICALS INC | AUPH | $918,592 | 1.55% |
| SAREPTA THERAPEUTICS INC | SRPT | $917,780 | 1.55% |
| REGENERON PHARMACEUTICALS | REGN | $902,209 | 1.52% |
| BRIDGEBIO PHARMA INC | BBIO | $895,417 | 1.51% |
| VERTEX PHARMACEUTICALS INC | VRTX | $894,506 | 1.51% |
| BEONE MEDICINES LTD | ONC | $875,476 | 1.48% |
| IONIS PHARMACEUTICALS INC | IONS | $875,290 | 1.48% |
| MADRIGAL PHARMACEUTICALS INC | MDGL | $856,280 | 1.44% |
| KURA ONCOLOGY INC | KURA | $817,649 | 1.38% |
| NEUROCRINE BIOSCIENCES INC | NBIX | $815,301 | 1.38% |
| PTC THERAPEUTICS INC | PTCT | $813,901 | 1.37% |
| ACADIA PHARMACEUTICALS INC | ACAD | $782,495 | 1.32% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | $757,204 | 1.28% |
| TARSUS PHARMACEUTICALS INC | TARS | $739,912 | 1.25% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $736,277 | 1.24% |
| HARMONY BIOSCIENCES HOLDINGS INC | HRMY | $730,234 | 1.23% |
| PHATHOM PHARMACEUTICALS INC | PHAT | $727,966 | 1.23% |
| CRINETICS PHARMACEUTICALS INC | CRNX | $726,854 | 1.23% |
| IMMUNOCORE HOLDINGS PLC | IMCR | $717,678 | 1.21% |
| RHYTHM PHARMACEUTICALS INC | RYTM | $677,973 | 1.14% |
| INSMED INC | INSM | $654,520 | 1.10% |